tiprankstipranks

Caley Castelein Insider Profile

11 Followers
Caley Castelein, Director at Whitehawk Therapeutics, holds 2.44M shares in Whitehawk Therapeutics (Ticker: WHWK), holds 0.00 shares in Tourmaline Bio (Ticker: TRML), holds 99.05K shares in Viewray (Ticker: VRAYQ).
tipranks
Caley Castelein

Caley Castelein
Whitehawk Therapeutics (WHWK)
Director

Ranked #51,463 out of 108,921 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+4.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
0.00%
A breakdown of Caley Castelein's holdings

Insider Roles

Whitehawk Therapeutics
(WHWK)
Director
Viewray
(VRAYQ)
Director
Roles that Caley Castelein holds in companies

Most Profitable Insider Trade

Stock:
Tourmaline Bio
(TRML)
Rating:Informative Buy
Date:Oct 27, 2023 - Oct 27, 2024
Return:+89.90%
The most profitable trade made by Caley Castelein

Caley Castelein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Whitehawk Therapeutics
May 18, 2026
Director
Uninformative Buy
1000.00K
$10.03M
TRML
Tourmaline Bio
Oct 28, 2025
Uninformative Sell
$0.00
Viewray
Jul 21, 2023
Director
Informative Sell
162.57K
List of latest transactions for each holding click on a transaction to see Caley Castelein's performance on stock

Caley Castelein insider profile FAQ

What is the percentage of profitable transactions made by Caley Castelein?
The percentage of profitable transactions made by Caley Castelein is 50%.
    What is the average return per transaction made by Caley Castelein?
    The average return per transaction made by Caley Castelein is 4.70%.
      What stocks does Caley Castelein hold?
      Caley Castelein holds: WHWK, TRML, VRAYQ stocks.
        What was Caley Castelein’s latest transaction?
        Caley Castelein latest transaction was an Uninformative Buy of $1000.00K.
          What was Caley Castelein's most profitable transaction?
          Caley Castelein’s most profitable transaction was an Informative Buy of TRML stock on October 27, 2023. The return on the trade was 89.90%.
            What is Caley Castelein's role in Whitehawk Therapeutics?
            Caley Castelein's role in Whitehawk Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.